Magnus Gisslén

15.6k citations
268 papers · 8.2k indexed · 2 hit papers · h-index 51
  • Virology top 0.05%
    • HIV Research and Treatment 185
    • HIV/AIDS Research and Interventions 134
    • HIV/AIDS drug development and treatment 56
    • COVID-19 Clinical Research Studies 41
    • SARS-CoV-2 and COVID-19 Research 29
    • HIV-related health complications and treatments 79
  • Neurology top 0.5%
    • Long-Term Effects of COVID-19 18
    • Cytomegalovirus and herpesvirus research 27

Magnus Gisslén

256 papers receiving 8.1k citations

Hit Papers

Cognitive impairment i...662015202620182022100200300

Peers

Magnus Gisslén
Comparison fields: 5 of 144
  • Virology 4.9k
  • Infectious Diseases 4.6k
  • Emergency Medicine 2.2k
  • Biological Psychiatry 419
  • Neurology 1.2k
Replace Serena Spudich with:
Serena Spudich United States
Victor Valcour United States
David B. Clifford United States
Elyse J. Singer United States
Ned Sacktor United States
Benjamin B. Gelman United States
Richard L. Skolasky United States
Leon G. Epstein United States
Scott Letendre United States
Christina M. Marra United States
Magnus Gisslén relative to Serena Spudich United States Serena Spudich's profile →
Citations per field
00.5×1.5×
Serena Spudich · 1×
Citations per year

Countries citing papers authored by Magnus Gisslén

Since Specialization
Citations

This map shows the geographic impact of Magnus Gisslén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Gisslén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Gisslén more than expected).

Fields of papers citing papers by Magnus Gisslén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnus Gisslén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Gisslén. The network helps show where Magnus Gisslén may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Magnus Gisslén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Magnus Gisslén Line = papers co-authored together Magnus Gisslén links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20251
4 20250
5 20244
6 20244
7 20246
8 20233
9 20235
10 20233
11 202311
12 202213
13 2021109
14 202114
15 202137
16 20210
17 20207
18 202013
19 201858
20 200417

About Magnus Gisslén

Magnus Gisslén is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 268 papers that have together received 8.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (185 papers), HIV/AIDS Research and Interventions (134 papers), HIV-related health complications and treatments (79 papers), HIV/AIDS drug development and treatment (56 papers), COVID-19 Clinical Research Studies (41 papers), SARS-CoV-2 and COVID-19 Research (29 papers), Cytomegalovirus and herpesvirus research (27 papers) and Long-Term Effects of COVID-19 (18 papers). The work is most often cited by research in Virology (4.9k citations), Infectious Diseases (4.6k citations) and Emergency Medicine (2.2k citations). Magnus Gisslén has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Richard W. Price, Lars Hagberg, Dietmar Fuchs, Serena Spudich, Henrik Zetterberg, Staffan Nilsson, Paola Cinque, Aylin Yilmaz, Kaj Blennow and Bo Svennerholm. Their work appears in journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026